DE69526738T2 - Endothelin-rezeptor-antagonisten - Google Patents

Endothelin-rezeptor-antagonisten

Info

Publication number
DE69526738T2
DE69526738T2 DE69526738T DE69526738T DE69526738T2 DE 69526738 T2 DE69526738 T2 DE 69526738T2 DE 69526738 T DE69526738 T DE 69526738T DE 69526738 T DE69526738 T DE 69526738T DE 69526738 T2 DE69526738 T2 DE 69526738T2
Authority
DE
Germany
Prior art keywords
endothelin receptor
receptor antagonist
novel
compounds
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69526738T
Other languages
English (en)
Other versions
DE69526738D1 (de
Inventor
Duncan Elliott
Joseph Weinstock
Jia-Ning Xiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE69526738D1 publication Critical patent/DE69526738D1/de
Publication of DE69526738T2 publication Critical patent/DE69526738T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69526738T 1994-09-02 1995-08-28 Endothelin-rezeptor-antagonisten Expired - Lifetime DE69526738T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30082994A 1994-09-02 1994-09-02
US37531895A 1995-01-18 1995-01-18
US47699295A 1995-06-07 1995-06-07
PCT/US1995/010885 WO1996007653A1 (en) 1994-09-02 1995-08-28 Endothelin receptor antagonists

Publications (2)

Publication Number Publication Date
DE69526738D1 DE69526738D1 (de) 2002-06-20
DE69526738T2 true DE69526738T2 (de) 2003-02-06

Family

ID=27404770

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69526738T Expired - Lifetime DE69526738T2 (de) 1994-09-02 1995-08-28 Endothelin-rezeptor-antagonisten

Country Status (6)

Country Link
EP (1) EP0778833B1 (de)
JP (1) JPH10505085A (de)
AT (1) ATE217619T1 (de)
AU (1) AU3416995A (de)
DE (1) DE69526738T2 (de)
WO (1) WO1996007653A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO115802B1 (ro) * 1995-08-02 2000-06-30 Smithkline Beecham Corporation Derivaţi ai acidului pirazol dihidrobenzofuranil propenoic, intermediar pentru prepararea acestora, compoziţii farmaceutice ale acestora şi metodă de tratament
US6030970A (en) * 1995-08-02 2000-02-29 Smithkline Beecham Corporation Endothelin receptor antagonists
EP0841926B1 (de) * 1995-08-02 2003-03-26 Smithkline Beecham Corporation Endothelinrezeptorantagonist
JP2000502104A (ja) * 1995-12-21 2000-02-22 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体アンタゴニスト
JP2000504012A (ja) * 1996-02-01 2000-04-04 スミスクライン・ビーチャム・コーポレイション エンドセリンレセプターアンタゴニスト
EP0885217A4 (de) * 1996-02-01 1999-04-21 Smithkline Beecham Corp Endothelinrezeptor-antagonisten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006137A (en) * 1975-08-21 1977-02-01 E. R. Squibb & Sons, Inc. 2-Ethenyl imidazolium derivatives
JPH0680057B2 (ja) * 1986-04-28 1994-10-12 保土谷化学工業株式会社 トリフエニルイミダゾ−ル及びその二量体
DE69034103T2 (de) * 1989-06-14 2004-07-15 Smithkline Beecham Corp. Imidazoalkensäure
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
JP3214856B2 (ja) * 1990-12-14 2001-10-02 スミスクライン・ビーチャム・コーポレイション イミダゾリル−アルケン酸
EP0650484B1 (de) * 1992-07-17 2000-01-26 Smithkline Beecham Corporation Endothelin rezeptor antagonisten

Also Published As

Publication number Publication date
ATE217619T1 (de) 2002-06-15
EP0778833B1 (de) 2002-05-15
JPH10505085A (ja) 1998-05-19
AU3416995A (en) 1996-03-27
EP0778833A1 (de) 1997-06-18
WO1996007653A1 (en) 1996-03-14
DE69526738D1 (de) 2002-06-20
EP0778833A4 (de) 1998-12-16

Similar Documents

Publication Publication Date Title
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
BR0010215A (pt) Derivados de indolina como antagonistas de progesterona
PT935465E (pt) Compostos novos de imidazole substituido
BR9706973A (pt) Novos compostos de imidazol substituídos
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
BR0016396A (pt) Novos antagonistas do receptor p2x7 para uso no tratamento de doenças inflamatórias, imunes ou cardiovasculares
DK0747050T4 (da) Farmaceutiske sammensætninger, der indeholder irbesartan
ES2175066T3 (es) Antagonistas triciclicos de la vasopresina.
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
TR200002896T2 (tr) Kalsilitik Bileşimler
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
TR200200795T2 (tr) 5-HT1B antagonistleri olarak piperazin türevleri
SE9702773D0 (sv) Novel compounds
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
EP1244452A4 (de) Urotensin-ii rezeptorantagonisten
BG106930A (en) Substituted phenyl-piperazine derivatives, their preparation and use
SE9802937D0 (sv) Novel compounds
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
DE50008020D1 (de) Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten
DE69703242T2 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69526738T2 (de) Endothelin-rezeptor-antagonisten
DE60015187D1 (de) Urotensin-ii rezeptorantagonisten
ES2166462T3 (es) Antagonistas del receptor de la endotelina.
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten